Squarepoint
MCRB icon

Squarepoint’s Seres Therapeutics MCRB Stock Holding History

Squarepoint’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$38.6K Buy
+11,523
New +$58.1K ﹤0.01% 4302
2025
Q3 		– Sell
-20,908
Closed -$232K – 4727
2025
Q2 		$232K Buy
+20,908
New +$184K ﹤0.01% 3879
2024
Q4 		– Sell
-2,237
Closed -$42.3K – 5320
2024
Q3 		$42.3K Buy
+2,237
New +$45.4K ﹤0.01% 3990
2024
Q1 		– Sell
-5,700
Closed -$160K – 4350
2023
Q4 		$160K Buy
+5,700
New +$150K ﹤0.01% 3665
2022
Q3 		– Sell
-1,895
Closed -$130K – 3240
2022
Q2 		$130K Buy
+1,895
New +$163K ﹤0.01% 2582
2022
Q1 		– Sell
-968
Closed -$161K – 3252
2021
Q4 		$161K Buy
+968
New +$154K ﹤0.01% 2788
2021
Q3 		– Sell
-718
Closed -$342K – 3216
2021
Q2 		$342K Sell
718
-6,401
-90% -$2.7M ﹤0.01% 2427
2021
Q1 		$2.93M Buy
7,119
+33
+0.5% +$15.2K 0.02% 876
2020
Q4 		$3.47M Buy
7,086
+1,609
+29% +$942K 0.03% 644
2020
Q3 		$3.1M Sell
5,477
-454
-8% -$151K 0.04% 503
2020
Q2 		$565K Buy
5,931
+3,249
+121% +$285K 0.01% 1254
2020
Q1 		$191K Sell
2,682
-10,882
-80% -$730K ﹤0.01% 1489
2019
Q4 		$936K Buy
13,564
+10,889
+407% +$808K 0.01% 1367
2019
Q3 		$215K Buy
+2,675
New +$177K ﹤0.01% 2047
2018
Q3 		– Sell
-684
Closed -$118K – 2114
2018
Q2 		$118K Buy
+684
New +$112K ﹤0.01% 1625

Other funds holding MCRB

Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J. Safra Sarasin Holding
J. Safra Sarasin Holding $7.05B AUM 26.14% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Rachor Investment Advisory Services
Rachor Investment Advisory Services Linden, Michigan $207M AUM 7.36% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Squarepoint's MCRB Position: Q3 2026 in Review

Squarepoint opened a new position in Seres Therapeutics (MCRB) in Q3 2026: 11,523 shares worth $38.6K. The stake represents ﹤0.01% of the portfolio and ranks #4302 among its holdings. This is a return to the name: Squarepoint previously reported a position in MCRB as recently as Q2 2025.

Squarepoint first reported a position in MCRB in Q2 2018 and has held it in 15 quarters since. The position peaked at $3.47M in Q4 2020. 13 funds tracked by Wall St. Rank hold MCRB as of Q3 2026.

  • Squarepoint held 11,523 shares of Seres Therapeutics worth $38.6K as of Q3 2026.
  • Seres Therapeutics was a new Squarepoint position in Q3 2026.
  • Seres Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4302 holding.
  • Squarepoint first reported a position in Seres Therapeutics in Q2 2018 and has held it in 15 quarters since.
  • Squarepoint's Seres Therapeutics position peaked at $3.47M in Q4 2020.
  • 13 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.